Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.220
-0.060 (-4.69%)
Jun 12, 2025, 3:25 PM - Market open
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $75.58 million as of June 12, 2025. Its market cap has decreased by -66.32% in one year.
Market Cap
75.58M
Enterprise Value
-10.01M
1-Year Change
-66.32%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $75.58M, a decrease of -85.57%. That is a compound annual growth rate of -40.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2025 | 79.29M | -14.52% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 694.59B |
| Johnson & Johnson | 373.49B |
| AbbVie | 334.13B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.04B |
| Abbott Laboratories | 232.09B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.45B |